PosterSessionOnline

INTERNATIONAL SOCIETY ON THROMBOSIS AND HAEMOSTA..

ISTH 2025 Congress

June 21-25, Washington

N. Poster

Poster title

Applicant name

Status


PB-0006	PB0006 - Association of catestatin levels with prothrombotic state in peripheral vascular disease	Oleksii Korzh	Received

PB-0041	PB0041 - Symptomatic Ischemic Stroke in Lung Cancer Patients with Subclinical Infarctions on Staging MRI	Avi Leader	Received

PB-0045	PB0045 - Using data-trained neural networks of platelet phenotypes to simulate thrombosis under stenotic flow	Scott Diamond	Received

PB-0057	PB0057 - Diagnostic performance of commercial antithrombin activity assays: do we get what we expect?	Christelle Orlando	Received

PB-0065	PB0065 - Evaluating DIC resolution as a surrogate outcome for mortality in sepsis-associated DIC	Tomoki Tanigawa	Received

PB-0066	PB0066 - Evaluating the Risk of Thrombosis Associated with Protein C Deficiency Using Population-Scale Data	Alfonso Rodriguez Espada	Received

PB-0072	PB0072 - Germline Loss of Function in SERPING1 (C1 Inhibitor) is a Multi-Phenotypic Thrombotic Disorder	Alfonso Rodriguez Espada	Received

PB-82	PB0082 - Inhibitory mechanisms of a tick salivary serpin on human haemostasis	Ingrid Dijkgraaf	Received

PB-0084	PB0084 - Investigating the Mechanisms of ADAMTS13 Metalloprotease Domain Latency	Peter Andrisani	Received

PB-0086	PB0086 - Large scale unbiased proteomics uncovers novel pathways and biomarkers for VWD Type 1	Brooke Sadler	Received

PB-0089	PB0089 - Modulating Endothelial Thromboinflammation Biomarkers in Diabetic Convalescent COVID-19 Patients	Alejandro gonzalez ochoa	Received

PB-0112	PB0112 - The Clinical Utility of ADAMTS-13 Testing: An Audit of Assay Requests in a Tertiary hospital	Ghadah Al yami	Received

PB-119	PB0119 - Two Phase 3 studies on antithrombin concentrate in congenital and acquired antithrombin deficiency	Sarah Baker	Received

PB-0120	PB0120 - Unveiling the Impact of Antithrombin Levels in Heparins Anticoagulant Effect: An In Vitro Analysis	Eugenio Rosado	Received

PB-0123	Von Willebrand factor A1 blockade prevents platelet-mediated reocclusion in a microfluidic model of arterial thrombosis	Ronit Kar	Received

PB-0124	PB0124 - Von Willebrand Factor and ADAMTS13 in major adverse limb events in peripheral artery disease	Vinai Bhagirath	Received

PB-128	PB0128 - Accurate measurement of edoxaban concentration after reversal by andexanet alpha	Sho Shinohara	Received

PB-0130	PB0130 - Advancing Understanding of Cellular Deposition and Thrombosis in Extracorporeal Oxygen Therapy	Tyler Hughes	Received

PB-0144	PB0144 - Clot waveform analysis in patients with hemophilia A B and their related disease	Teruhisa Fujii	Received

PB-0147	PB0147 - Comparative study of four platelet function tests calculated through two techniques	Tasuku Sakayori	Received

PB-158	PB0158 - Effect of Mim8 and Emicizumab on Factor VIII Recovery by a Novel Bovine Chromogenic FVIII Assay	Elaine Benoit	Received

PB-0169	PB0169 - Impact of factor VIII activity chromogenic assay in the diagnosis of mild hemophilia A	Virginie Barbay	Received

PB-171	PB0171 - Impact of Underfilled Samples from Three Tube Manufacturers on Coagulation Laboratory Tests	Lee Beckett	Received

PB-0172	PB0172 - Improved APTT correlation with anti-Xa and anti-IIa using heparin resistant recalcification	stephen macdonald	Received

PB-176	PB0176 - Method comparison study of activated partial thromboplastin time reagents	Jordan Jones	Received

PB-0184	PB0184 - Platelet Function Testing in Fresh vs. Shipped Blood Samples Under Real-World Conditions	ANA MARIN QUILEZ	Received

PB-0186	PB0186 - Prediction of Perioperative ischemic events in neuroendovascular treatments by APAL system.	Tasuku Sakayori	Received

PB-209	PB0209 - Valuable chromogenic assay to assess the efficacy of the reversal by Andexanet-alpha	CLAIRE DUNOIS	Received

PB-223	PB0223 - CRYOFIBRINOGENEMIA: major role of fibrinogen and albumin synergism in increased soluble fibrin level	Dennis Galanakis	Received

PB-0230	PB0230 - Elevated lipoprotein(a) links with fibrinolysis and valvular calcification in aortic stenosis	Anna Hojda	Received

PB-0248	HPB0248 - Monitoring response to therapeutic interventions in a patient with a fibrinolytic pathway defect	Maria Notini	Received

PB-0251	PB0251 - Protein carbonylation as a modulator of fibrin clot properties in thyroid disorders	Anna Hojda	Received

PB-0269	PB0269 - CLINICAL IMPLICATIONS OF HEMOPHILIA TREATMENT CENTERS IN DEVELOPING COUNTRIES	Emina Suljovic-Hadzimesic	Received

PB-0272	PB0272 - Comparability of human and bovine cFVIII assay in mild haemophilia A with FVIII assay discrepancy.	Jireh Ann Batac	Received

PB-279	PB0279 - Effectiveness and safety of damoctocog alfa pegol extended dosing regimens in hemophilia A	Amanda Ward	Received

PB-0280	PB0280 - Effectiveness of emicizumab in hemophilia A: 4th interim analysis of the real-world study EMIIL	Petra Joestingmeyer	Received

PB-0286	PB0286 - Factor activity bleeding phenotype and delivery outcomes in Hemophilia A and B carriers	Valerie Gao	Received

PB-0291	PB0291 - Haemophilia in East Mediterranean: Trends in Prevalence and Treatment Use (2014-2022)	Abdulrahman Algarni	Received

PB-293	PB0293 - HEM-POWR interim analysis of damoctocog alfa pegol in patients with hemophilia A in Canada	Amanda Ward	Received

PB-0296	PB0296 - INHIBIT: A study of inhibitors and biomarkers in previously untreated Hemophilia A patients	Nicoletta Machin	Received

PB-0304	PB0304 - Multidisciplinary Care and Quality of Life in Colombian Adults with Hemophilia: A Cross-Sectional Study	JUAN GUILLERMO DUQUE ORTEGA	Received

PB-0314	PB0314 - Recombinant Activated Factor VIIa Combined with Tranexamic Acid Control Hemostasis in Patients with	Galia Spectre	Received

PB-0320	PB0320 - Succesful repeated angiographic embolization of the genicular arteries in a patient with hemophilia B and an inhibitor	ANGELIKA BÁTOROVÁ	Received

PB-0330	PB0330 - Why genotype? Results of a survey of U.S. providers utilizing a hemophilia A genotyping program	Greg Melroe	Received

PB-0344	PB0344 - Bleeding and Thrombosis Risks with Danaparoid Sodium in HIT: A Retrospective Study	david smadja	Received

PB-0348	PB0348 - Consistent Response to Avatrombopag for Pediatric ITP Across Various Baseline Characteristics	Scott Kolodny	Received

PB-0353	PB0353 - Early initiation of TPO-RA reduces total corticosteroid dose in adult ITP:Japanese database analysis	Kodai Suzuki	Received

PB-354	PB0354 - Early Platelet Count Indicators of Heparin-Induced Thrombocytopenia After Major Cardiac Surgery	Ishac Nazy	Received

PB-0356	PB0356 - Effectiveness and safety of avatrombopag in ITP patients switching from eltrombopag or romiplostim	CRISTINA IZQUIERDO	Received

PB-0363	PB0363 - Evaluation of a Chemiluminescent IgG Anti-PF4/H Assay for heparin-induced thrombocytopenia diagnosis	Nicolas Gendron	Received

PB-0364	PB0364 - Evaluation of Efficacy and Safety of Avatrombopag in Children with ITP Based on Disease Duration	Scott Kolodny	Received

PB-0366	PB0366 - FLORIO ITP MOBILE APP: A REVOLUTION IN ITP MONITORING.	Sara Montolío Chiva	Received

PB-0368	PB0368 - GPVI is a receptor for the PF4/anti-PF4 IgG complex and mediates platelet activation in HIT	Ivo Francischetti	Received

PB-369	PB0369 - Guideline on the Management of Critical Bleeding in Patients with Immune Thrombocytopenia	Donald Arnold	Received

PB-0373	PB0373 - Immune thrombocytopenia and primary immunodeficiencies. Series of 6 cases.	CRISTINA PASCUAL- IZQUIERDO	Received

PB-384	PB0384 - Pirtobrutinib in Adults with Immune Thrombocytopenia: A Phase 1/2 Dose-finding Study in Progress	Abby Atwater	Received

PB-0400	PB0400 - Validation of a New Automated Chemiluminescent Immunoassay for the detection of anti-platelet factor 4/heparin (PF4/H) IgG antibodies	Lily Zhang	Received

PB-402	PB0402 - Cancer-activated endothelial and cancer cells synergize to enhance thrombin generation in tumors	Mohammed Baghdadi	Received

PB-0403	PB0403 - Circulating Tumour Cells alter vascular inflammation CD73 and cfDNA release in ovarian cancer	Lucy Norris	Received

PB-0407	PB0407 - High-Sensitivity C-Reactive Protein and Fibrinogen for the Prediction of Thrombosis in Lung Cancer	Patricia Gomez Rosas	Received

PB-0428	PB0428 - Analysis of Real-World Methods of Identifying Venous Thromboembolic Events in Patients with Cancer	Aysswarya Manoharan	Received

PB-0430	PB0430 - Anticoagulation Management In Patients With Cancer-Associated Small Venous Thromboembolism	KOU ROGER	Received

PB-431	PB0431 - Apixaban and tinzaparin reverse anticancer drug resistance caused by fibrin clot shields in tumors	Patrick Van Dreden	Received

PB-0439	PB0439 - Catestatin and relaxin-2 in platelet activation and blood coagulation in venous thromboembolism	Oleksii Korzh	Received

PB-0442	PB0442 - Circulating Vascular Endothelial Growth Factor Level in venous thromboembolic Disorder	Chandan Mohapatra	Received

PB-0447	PB0447 - Coagulation biomarkers postoperative thromboembolism and survival in ovarian cancer	Lasse Myllylahti	Received

PB-0454	PB0454 - Direct oral anticoagulant in thromboembolism prophylaxis after hip fracture surgery in Thai patients	Pitiphong Kijrattanakul	Received

PB-455	PB0455 - Effects of human derived plasminogen on fibrinolytic activity in experimental murine venous thrombos	Satish Kumar Devarapu	Received

PB-0457	PB0457 - Efficacy and safety of direct oral anticoagulants for treatment of cancer-associated venous thromboembolism: a real-life uruguayan registry	Ana Pizzarossa	Received

PB-0467	PB0467 - Impact of body mass index on the utility of D-dimer in cancer patients with deep vein thrombosis	Tatsuya Konishi	Received

PB-470	PB0470 - Implementation of Venous Thromboembolism Prophylaxis in Hospitals	Vishnu Prasad	Received

PB-0473	PB0473 - Incidence of thromboembolic and bleeding events in a cohort of patients with unresectable hepatocellular carcinoma on systemic therapy	Elena Butera	Received

PB-0485	PB0485 - Management of lesser saphenous vein thrombosis close to the saphenopopliteal junction: A UK Survey.	Kirollos Kamel	Received

PB-0492	PB0492 - Prescription of pharmacological thromboprophylaxis in medical patients: Experience with 2 risk assessment models in two tertiary centres in Uruguay	Ana Pizzarossa	Received

PB-0493	PB0493 - Prevalence and clinical associations of IgA antiphospholipid antibodies in APS and SLE	Maria Efthymiou	Received

PB-0505	PB0505 - Safety of D-dimer testing to rule out pulmonary embolism in patients with cancer	Kristina Vrotniakaite-Bajerciene	Received

PB-0515	PB0515 - Thromboembolism and Bleeding in Multiple Myeloma: Rates Risk Profiles and Thromboprophylaxis	Julia Riedl	Received

PB-0517	PB0517 - Thrombosis risks in prostate cancer patients on oral anticoagulants and enzalutamide/apalutamide	Tzu-Fei Wang	Received

PB-0534	PB0534 - Antithrombin replacement prior to delivery in pregnant women with hereditary antithrombin deficiency	Maria Teresa De Sancho	Received

PB-0537	PB0537 - Bleeding Disorders and Obstetric Challenges: A Retrospective Analysis of a Majority Hispanic Cohort	Kamilia Moalem	Received

PB-0539	PB0539 - Challenges in Pregnancy and Delivery for Women with Hemophilia and Carriers: a 10-Year Analysis	Mariasanta Napolitano	Received

PB-0543	PB0543 - Comparison of Machine Learning classifiers for hypercoagulability associated risk of IVF failure.	Patrick Van Dreden	Received

PB-544	PB0544 - Comparison of VTE prevention guidelines during hospitalization in pregnancy: cost-effectiveness.	VENINA BARROS	Received

PB-547	PB0547 - D-dimer in Pregnancy Clinical Significance	Maria Hulikova	Received

PB-0554	PB0554 - Factor IX levels Can Increase in Pregnancy in Carriers of Haemophilia B	Claire Kelly	Received

PB-0567	PB0567 - Management of Antithrombin deficiency in pregnancyReview of 4 cases managed at Royal Free Hospital	Yawar Yaseen	Received

PB-0574	PB0574 - Reproductive Tract Bleeding in Adolescent Females on Anticoagulation and/or Antiplatelet Therapy- A Systematic Review	Neeraja Swaminathan	Received

PB-588	PB0588 - Transcutaneous Auricular Neurostimulation to Reduce Heavy Menstrual Bleeding	Christopher Czura	Received

PB-0590	PB0590 - Uterine Bleeding in Patients with Venous Thrombosis and Association with Sex of Treating Clinician	Rachel Rosovsky	Received

PB-0601	PB0601 - A Quarterly Audit to Assess Venous Thromboembolism Prevention Management in Hospital Inpatients	Mohamed Shaisha	Received

PB-0602	PB0602 - A systematic review on anti-Xa monitoring in the therapeutic use of Low-Molecular-Weight Heparins	Nakisa Khorsand	Received

PB-0605	PB0605 - An Audit to Assess Therapeutic Unfractionated Heparin (UFH) for Hospital Adult Inpatients	Mohamed Shaisha	Received

PB-0619	PB0619 - Arterial Thromboembolism in Patients with Cancer-Associated Thrombosis: A Meta-Analysis	Cilomar Martins de Oliveira Filho	Received

PB-0624	PB0624 - Clinical and Pharmacogenetic Analysis of DOACs in Elderly Patients with Frailty	Diego Servidio	Received

PB-625	PB0625 - Clinical Outcomes of Venous Thromboembolism: Insights from Thailand GARFIELD-VTE Registry	Sithakom Phusanti	Received

PB-0629	PB0629 - Comparison of inhibitory effects between FXIa inhibitors and DOACs in thrombin generation assay	Osamu Kumano	Received

PB-634	PB0634 - Development of a Thrombin Generation Assay for the Assessment of Novel Factor XI Inhibitors	Beth Bouchard	Received

PB-0635	PB0635 - Direct comparison of inhibitory effects by one-stage assay in factor XIa inhibitors	Osamu Kumano	Received

PB-0636	PB0636 - Direct oral anticoagulants and telephonic follow-up consultations.The importance of Close Monitoring	Angel Horrillo Orejudo	Received

PB-638	PB0638 - Dose escalation effects of intravenous APAC a heparin proteoglycan mimic in healthy participants	Riitta Lassila	Received

PB-657	PB0657 - Implementation of Direct Oral Anticoagulant Perioperative Interruption Protocol	David Gimelfarb	Received

PB-0658	PB0658 - Improving Safe Anticoagulant Prescribing with Prescriber-Pharmacist Partnership: A Randomized Trial	Geoffrey Barnes	Received

PB-0665	PB0665 - Long term outcomes of a multicenter aspirin deprescribing intervention	Avilasha Sinha	Received

PB-0669	PB0669 - New USP28 agonists and USP40 inhibitors with cardioprotective and antithrombotic effects	Aleksandr Samorodov	Received

PB-0673	PB0673 - Patient Satisfaction with Anticoagulant Therapy for VTE. A Systematic Literature Review	Patrick Van Dreden	Received

PB-0675	PB0675 - Pediatric Middle Cerebral Artery Stroke due to coil embolization: Anticoagulation Management	Alexander Hsu	Received

PB-676	PB0676 - Periprocedural Anticoagulant Management: Computerized Decision Support System Concordance Testing	Amulya Bhagirath	Received

PB-0679	PB0679 - Pharmacokinetics and Pharmacodynamics of Phosphodiesterase 4 Inhibition in a Low Flow ECMO Model	Andrew Meyer	Received

PB-0684	PB0684 - Procoagulant state modulates the effect of direct oral anticoagulants in cirrhosis	Cindy Pereira Portela	Received

PB-0685	PB0685 - Racial Disparities in Bleeding during Extended Anticoagulant Therapy for Venous Thromboembolism	Yan Xu	Received

PB-0687	PB0687 - Reagent variability of APTT prolongation in factor XIa inhibitors of asundexian and milvexian	Osamu Kumano	Received

PB-0689	PB0689 - Real-world utilisation of Andexanet-Alfa: A single centre experience	Niamh Loughran	Received

PB-0701	PB0701 - The SYK inhibitor Bi 1002494 ively impairs thrombosis structure in a murine femoral artery ferric chloride-induced occlusion model without affecting puncture wound hemostasis structure	Brian Storrie	Received

PB-706	PB0706 - Title: Efficacy and Safety of Direct Oral Anticoagulants Versus Warfarin in the Management of Chronic Portal Vein Thrombosis in Cirrhotic Patients - A Retrospective Study	Gary Batra	Received

PB-0707	PB0707 - Upper Extremity Superficial Venous Access in Ultrasound-Assisted Thrombolysis for Pulmonary Embolism	Ilham Benzidia	Received

PB-0715	PB0715 - Analysis of clot properties via thromboelastography compared to plasma fibrin clot characteristics	Anna Hojda	Received

PB-0723	PB0723 - Blood inflammatory factors as risk factors in the diagnosis of thrombotic thrombocytopenia purpura	XU YE	Received

PB-0725	PB0725 - Clinical Outcomes of Genetic Panel Testing for Inherited Bleeding Disorders: Genomic MDT Case Review	Alan Mitchell	Received

PB-0732	PB0732 - Disease-Specific Expertise for the Development of NGS Panels for Inherited Hemostatic Disorders	Julie Majerus	Received

PB-0736	PB0736 - F8 variants in intron 1 may disrupt transcriptional enhancers causing haemophilia A.	Yohann JOURDY	Received

PB-0739	PB0739 - Genetic test utilization for hemostatic disorders: experience of a reference laboratory	Christine Koellner	Received

PB-0743	PB0743 - Impact of Extended Half-Life Factor VIII on Pharmacokinetics and Bleeding Rates in Hemophilia A	Natalia duque Zapata	Received

PB-0749	PB0749 - Machine Learning Algorithms for Predicting Recurrent Thrombotic Events in Antiphospholipid Syndrome	Ana Marco-Rico	Received

PB-772	PB0772 - A specific FX activator for bleeding episodes treatment in hemophilia with inhibitor	Ada Zhang	Received

PB-774	PB0774 - Acquired Haemophilia A: Current Treatment and Outcomes in New South Wales Australia	Vickie Lee	Received

PB-778	PB0778 - Addressing unmet medical needs and health inequities in haemophilia A: expert consensus statements	Tyrone Daniel	Received

PB-0779	PB0779 - Advancing Hemophilia A Management with the Portability of Turoctocog Alfa Pegol (N8-GP)	Angel Horrillo Orejudo	Received

PB-792	PB0792 - Cardiovascular safety of emicizumab in older patients: findings from a large unbiased cohort	Quentin Van Thillo	Received

PB-798	PB0798 - Early emicizumab prophylaxis does not prevent FVIII inhibitor occurrence in MTP with severe HA	Tami Barazani Brutman	Received

PB-0803	PB0803 - Efficacy of concizumab prophylaxis in patients with Hemophilia:A systematic review and meta-analysis	Bezalel Hakkeem	Received

PB-0809	PB0809 - Emicizumab in Patients with Severe Haemophilia A without Inhibitors: A Single Center Experience	Monika Biernat	Received

PB-810	PB0810 - Emicizumab provides excellent brain protection in a large unbiased retrospective cohort	Quentin Van Thillo	Received

PB-0811	PB0811 - Establishment of a multicenter prospective observational bleeding disorders registry in Japan	Takeshi Matsumoto	Received

PB-0816	PB0816 - Extravascular distribution of factor IX: evidence and relevance for hemophilia B replacement therapy	Liz Beatty	Received

PB-0822	Final analysis of the phase 1/2 trial of valoctocogene roxaparvovec for severe hemophilia A	Gillian Clague	Received

PB-0823	PB0823 - First Data from the American Thrombosis and Hemostasis Network Transcends Registry Hemophilia Gene Therapy Outcomes Arm	Janice Staber	Received

PB-0827	PB0827 - Gene therapy for hemophilia: Survey on care team knowledge attitudes and preparedness	Melissa Glasner	Received

PB-828	PB0828 - Gene Therapy in Hemophilia B: Innovative Methods to Evaluate Value Contribution	Isabel Cortés Lorenzo	Received

PB-0831	PB0831 - Hemoglobin increase in children with hemophilia A on emicizumab: HAVEN 2 & 7 post hoc analysis	Phoebe Tate	Received

PB-0854	PB0854 - Patient preferences for the treatments of hemophilia A and B in France.	Monia Ezzalfani	Received

PB-0857	PB0857 - Persistent Musculoskeletal Challenges Despite Emicizumab Benefits in Adult Haemophilia A Patients	Cedric Hermans	Received

PB-0866	PB0866 - Real world outcomes of acquired haemophilia A in 2025: An Australian single centre experience	PRATHEEPAN PUVANAKUMAR	Received

PB-868	PB0868 - Real-World Effectiveness and Usage of Recombinant Factor IX Fc: Final Data from the B-MORE Study	Costello Medical	Received

PB-0869	PB0869 - Real-world efficacy of concizumab prophylaxis in a patient with hemophilia B and inhibitors	Tefu Weng	Received

PB-0871	PB0871 - Reduced cytokine release by dendritic cells upon binding of factor VIII immune complexes to FcyRIIb	Mariarosaria Miranda	Received

PB-0875	PB0875 - Safety and efficacy of KN057 the first anti-TFPI monoclonal antibody in Chinese hemophilia patients	Mankai Ju	Received

PB-0877	PB0877 - SPK-8011 vector genome maintains an active transcriptional state for up to 72 weeks in adult mice	Helen Miller	Received

PB-0881	PB0881 - The impact of emicizumab on averted bleeds and hospitalization days in people with hemophilia A	Helen Miller	Received

PB-882	PB0882 - The impact of severe nutritional vitamin K deficiency on emicizumab therapy	Philip Wright	Received

PB-0887	PB0887 - WFH Gene Therapy Registry Governance: Advancing Global Research Collaboration & Patient Safety	Mayss Naccache	Received

PB-888	PB0888 - WFH Living Guidelines Model The Process	Donna Coffin	Received

PB-0889	PB0889 - A Diagnostic Challenge for UK NEQAS (Blood Coagulation) Proficiency Testing Participants	Ian Jennings	Received

PB-0893	PB0893 - Do we need harmonisation in reporting haemostasis assay results to avoid errors?	Ian Jennings	Received

PB-0894	PB0894 - EFA and EMI spiked samples for NEQASBC and ECAT FVIII exercise Autumn 2024	christopher reilly-stitt	Received

PB-0895	PB0895 - Efanesoctocog alfa measurement data from exercise between NEQAS & ECAT participants Autumn 2024.	christopher reilly-stitt	Received

PB-0901	PB0901 - Monitoring and Adherence in LMICs: A PDSA-Based Quality Improvement Project Utilizing POCT INR Self-TestingOral - OR - Poster Presentation,PNS 02 - Poster networking session	Sumaira Khan	Received

PB-0902	PB0902 - Nurse-Led Quality Improvement: Streamlining Workflow in a Multidisciplinary Thrombosis Service	Elise Moore	Received

PB-0903	PB0903 - The generation gap to psychological difficulties in hemophilia carriers	tomie FUJII	Received

PB-0904	PB0904 - The Psychological and Emotional Impact of VTE: Results from a Qualitative Patient-Oriented Study	Stephanie Young	Received

PB-0913	PB0913 - Anticoagulation with rivaroxaban in pediatric oncology: a case series	Joyce C M Lam	Received

PB-0922	PB0922 - Clinical Characteristics in Children with Isolated Low Von Willebrand Factor Collagen Binding Activity	Fernando Corrales-Medina	Received

PB-0943	PB0943 - Identifying biomarkers of bleeding in babies undergoing cardiac surgery with cardiopulmonary bypass	Suelyn Van Den Helm	Received

PB-0946	PB0946 - Improving Time to Factor Therapy for Patients with Bleeding Disorders in the Emergency Department	Arun Gurunathan	Received

PB-0950	PB0950 - Local Experience with Subcutaneous Protein C Injection in Managing Homogeneous Protein C Deficiency.	Ohoud Kashari	Received

PB-0960	PB0960 - Pediatric Venous Thromboembolism and Bleeding from Thromboprophylaxis: An International Survey	Robert Huibonhoa	Received

PB-965	PB0965 - Post-Operative Antithrombosis Therapy for Congenital Cardiac Disease	Gregory Carlisle	Received

PB-0970	PB0970 - Quebec Platelet Disorder in Ashkenazi Jews : The surprising genetic diagnosis	Dror Levin	Received

PB-0976	PB0976 - Rivaroxaban levels monitorization in children: effect of age and weight on DOAC level	Ruben Berrueco	Received

PB-0980	PB0980 - Safety/efficacy of pharmacologic prophylaxis in hospitalized adolescents with sickle cell disease	Vilmarie Rodriguez	Received

PB-0981	PB0981 - Screening for Resistance to Activated Protein C Following Thrombosis in Young Patients	Marilyn Manco-Johnson	Received

PB-0982	PB0982 - Scurvy in a child with autism spectrum disorder: a case report	Dáyrton Moreira	Received

PB-0983	PB0983 - Successful pediatric endovascular thrombectomy in a case of infective endocarditis	Mark Grinberg	Received

PB-0986	PB0986 - Systematic review on the management of hemostatic defects in children with liver disease	Bhavya Doshi	Received

PB-997	PB0997 - Trends and Diagnostic Utility of PT and APTT in Coagulation Screens at a Tertiary Paediatric Centre	Gerard Gurumurthy	Received

PB-1001	PB1001 - Whole-vial emicizumab dosing in pediatric hemophilia A: real-world data insights	Sonata Saulyte Trakymiene	Received

PB-1019	PB1019 - Critical role for PP1 in megakaryocyte development signaling and hemostasis	Zoltan Nagy	Received

PB-1027	PB1027 - Effect of human mesenchymal stem cell-derived platelet like cells on a GVHD model using NOG mice	Yumiko Matsubara	Received

PB-1035	PB1035 - GP1BA-cre mice allow a strong recombination in pre Megakaryocyte-Erythroid progenitor.	Victor-Emmanuel Brett	Received

PB-1042	PB1042 - Identifying apoptosis and autophagy mechanisms in a megakaryocytic model of immune thrombocytopenia	Christina Bitsina	Received

PB-1044	PB1044 - Influence of recombinant factor VIII binding to platelets on fibrin clot formation and stability	Greg Melroe	Received

PB-1049	PB1049 - Loss of the Interaction Linking the &945;IIb Thigh Domain K514 to the &946;3 I-EGF2 domain E500 Leads to Constitutive &945;IIb&946;3 Activation	Lu Wang	Received

PB-1056	PB1056 - Mitochondrial DNA Enhances Adrenaline-Induced Platelet Activation in Type-II Diabetes Mellitus	Durre Shehwar	Received

PB-1062	PB1062 - Optimization Strategy for Rap1B-Targeting Single Domain Antibodies as Platelet Activation markers	maxime moulard	Received

PB-1066	PB1066 - Plasma PF4 as biomarker for platelet reactivity and bleeding risk in cardiac surgery with DAPT	david smadja	Received

PB-1077	PB1077 - Platelet products stored in plasma or additive solution differ in hemostatic function over storage	Jason Brandon	Received

PB-1078	PB1078 - Platelet TLT-1 shedding in health in trauma patients or patients with haemostatic complications.	Amandeep Kaur	Received

PB-1096	PB1096 - Unraveling the Composition of Aggregates in Cold-Stored Platelets	Irona Khandaker	Received

PB-1098	PB1098 - Validation of a platelet storage device for research assays and point-of-care applications	Arnold Ju	Received

PB-1125	PB1125 - Long-COVID patients exhibit continuing impairement of fibrinolysis	Tuukka Helin	Received

PB-1134	PB1134 - Overt DIC scores in sepsis leukemia and solid cancer: a nation-wide database study in Japan	Takashi Ito	Received

PB-1147	PB1147 - Serum levels of VEGF-A121 are associated with the disease severity of COVID-19	Takayuki Ikezoe	Received

PB-1148	PB1148 - Soluble P-Selectin and TXB2 but Not Circulating Cell-free DNA are diagnostic markers in HIT	Ivo Francischetti	Received

PB-1152	A Comprehensive Assessment of the Impact of COVID Variant and Vaccination on Venous Thromboembolism and Mortality	Samuel Soff	Received

PB-1159	PB1159 - Treatment of antiphospholipid-related libman-sacks endocarditis without systemic lupus erythematous.	Camille Durivage	Received

PB-1163	PB1163 - Analysis of Thrombin and Activated Protein C in Venous Thrombosis at Atypical and Typical Sites	Heiko Ruehl	Received

PB-1166	PB1166 - Clinician Recommendations for Post-Venous Thromboembolism Physical Activity: An International Survey	Anna Parks	Received

PB-1168	PB1168 - Genetic analysis of patients with chronic thromboembolic pulmonary hypertension (CTEPH)	Zsuzsanna Bereczky	Received

PB-1174	PB1174 - Non-invasive Imaging Accuracy in Portal Vein Thrombosis: A Systematic Review with Meta-Analysis	Laura Girardi	Received

PB-1185	PB1185 - 4-factor prothrombin complex concentrate for warfarin reversal with LVADs: a meta-analysis	Luísa Roxo	Received

PB-1188	PB1188 - Acquired Hemophilia A: insights from a 6-year experience in Liguria Italy	Angelo Claudio Molinari	Received

PB-1189	PB1189 - An Audit to Assess Andexanet Alfa for Major Bleeding with Factor Xa Inhibitors	Mohamed Shaisha	Received

PB-1191	PB1191 - Anticoagulation Management and Outcomes in Burns Patients	Mohamed Shaisha	Received

PB-1192	PB1192 - Assessing the pro-hemostatic effect of CAY001 on thrombin generation and thromboelastography	Damien Kudela	Received

PB-1194	PB1194 - Bleeding complications in patients with out-of-hospital cardiac arrest treated with cangrelor and oral P2Y12 inhibitors	Georg Gelbenegger	Received

PB-1199	PB1199 - Clinical practice guidelines for management of disseminated intravascular coagulation in Japan 2024.	YOSHINOBU SEKI	Received

PB-1207	PB1207 - Comparing trauma-induced coagulopathy in hip fracture surgery and elective hip arthroplasty: a thrombelastography study	Daniyya Chaudhry	Received

PB-1217	PB1217 - Early Intra-operative Use of a Fibrinogen Concentrate in Patients Undergoing Major Abdominal Surgery	Eugenio Rosado	Received

PB-1219	PB1219 - Efficacy and Safety of Fibrinogen Concentrate During Major Spinal Surgery: Phase 3 Randomized Trial	Eugenio Rosado	Received

PB-1224	PB1224 - Evaluation of Hemostatic Function of Stored Whole Blood in Different Storage Solutions for 35 days	Susan Shea	Received

PB-1234	PB1234 - Lupus anticoagulant interference in rotational thromboelastometry	Maximiliano Berro	Received

PB-1236	PB1236 - Management of acquired hemophilia A with emicizumab / rituximab: insights from the Vienna experience	Paul Knöbl	Received

PB-1244	PB1244 - PERFORMANCE OF DIC SCORING SYSTEMS & AT III FOR DIAGNOSIS OF DIC AND PREDICTION OF MORTALITY	ANJALI KELKAR	Received

PB-1249	PB1249 - Post-discharge bleeding in medical patients: External validation of the Intermountain risk score	Mansour Gergi	Received

PB-1250	PB1250 - Predicting Perioperative Bleeding in Hip Fracture Patients Using ISTH Criteria	Gareth Ryan	Received

PB-1251	PB1251 - Prediction of Cold-Stored Platelet Function Using Baseline Metrics	Irona Khandaker	Received

PB-1256	PB1256 - Rabbit Blood Banking: A Comparative Application for Transfusion	Lauren Jackson	Received

PB-1275	PB1275 - Use of andexanet alfa for direct oral anticoagulant reversion: a retrospective study in a tertiary h	Iarossi Michael	Received

PB-1276	PB1276 - Use of Fibrinogen Concentrate during Major Surgeries: Post-hoc Analysis of the Phase 3 AdFIrst Trial	Eugenio Rosado	Received

PB-1278	PB1278 - VMX-C001 bypasses the effects of FXa-direct oral anticoagulants in healthy adults: ROTEM analysis	Tainá Gomes	Received

PB-1283	PB1283 - Acquired factor V deficiency in China: clinical and laboratory features treatment and outcome	Mankai Ju	Received

PB-1293	PB1293 - Autosomal Recessive Factor V Deficiency Caused by Three Novel Variants	Natalie Montanez	Received

PB-1298	PB1298 - Citrullination in the C-terminus of TFPI-alpha impairs the inhibition of FV activation and of thrombin generation.	Rory Koenen	Received

PB-1300	PB1300 - Clinical performance evaluation of a new system for FXI level determination: sthemO XI on sthemO 301	Delphine Lavignasse	Received

PB-1301	PB1301 - Coagulation activation during human liver transplantation is associated with intrinsic pathway activation	Fynn Elvers	Received

PB-1314	PB1314 - Emicizumab-factor VIII association: impact on hemostasis tests and evaluation of hemostatic efficacy	Ladislas CAPDEVILA	Received

PB-1333	PB1333 - Modifying Variants That Alone are Sufficient to Reduce Factor VII Levels	Diane Nugent	Received

PB-1337	PB1337 - Mv-TF Procoagulant Phospholipid: Biomarkers of Severity in Hepatocellular Carcinoma and Cirrhosis	Patrick Van Dreden	Received

PB-1339	PB1339 - Non-Severe Hemophilia A: Relationship Among Mutations Factor VIII Levels and Thrombin Generation	Ana Marco-Rico	Received

PB-1341	PB1341 - Novel Variants in Fibrinogen Genes using a Customized 31-Gene Next-Generation Sequencing Panel	Diane Nugent	Received

PB-1342	PB1342 - Optimizing Hemostasis in Factor XI Deficiency: The role of Prophylactic Plasma Exchange	Roshan Afshan	Received

PB-1343	PB1343 - Parallelism in PT-based one stage extrinsic factor assays in normal subjects.	Susan Guy	Received

PB-1344	PB1344 - Parallelism in PT-based one-stage extrinsic factor assays in patients receiving anticoagulants	Susan Guy	Received

PB-1364	PB1364 - Tissue Factor-positive Microparticles and Risk of Thrombotic Complications in Sickle Cell Disease	Patrick Van Dreden	Received

PB-1365	PB1365 - UK NEQAS BC-Activated partial thromboplastin time Mixing Study survey-An updated review	Anna Williams	Received

PB-1367	PB1367 - Unravelling the role of coagulation factors in hemophilia A-associated bone metabolism	Jennifer Gebetsberger	Received

PB-1369	PB1369 - Utility of screening tests to diagnose factor deficiencies and lupus anticoagulant	Shoshana Revel-Vilk	Received

PB-1371	PB1371 - A novel p.C1130S mutation in a Finnish family with a complex phenotype of VWD	Timea Szanto	Received

PB-1372	PB1372 - A novel pathogenic variant VWF-Cys2750Phe in CK domain caused type 2A VWD	Linhua Yang	Received

PB-1375	PB1375 - A study of mood state using POMS2 in hemophilia patients	Aya Nakao	Received

PB-1378	PB1378 - Age-Based Differences in Ankle Joint Damage Progression in Severe Hemophilia A Patients	Te-Fu Weng	Received

PB-1379	PB1379 - Ageing related normalisation of Von Willebrand Factor - An Australian perspective	Fathima Ayyalil	Received

PB-1382	PB1382 - Assessing the impact of the 2021 VWD guidelines on the diagnosis/management of low VWF patients	Michael Dong	Received

PB-1383	PB1383 - Bleed experience in von Willebrand disease and validation of a Bleed and Medication Questionnaire	Helen Miller	Received

PB-1389	PB1389 - Clinical characteristics and pathogenesis of 20 female haemophilia patients from Chinaa multi-cente	Linhua Yang	Received

PB-1391	PB1391 - Clinical spectrum and treatment outcomes of Rare Bleeding Disorders in females	Kelly Davidson	Received

PB-1392	PB1392 - Concern about falling in the ageing hemophilia population: a nationwide questionnaire study	Amal Abdi	Received

PB-1395	PB1395 - Diagnosing Type 1 Von Willebrand disease using VWF:Act-to-FVIII Ratio: A retrospective study	Anshul Vagrecha	Received

PB-1397	PB1397 - Effect of age on ISTH-BAT scores and type 1 VWD diagnosis in the Zimmerman program	Ferdows Atiq	Received

PB-1399	PB1399 - Effectiveness and safety of damoctocog alfa pegol in patients with hemophilia A by body mass index	Amanda Ward	Received

PB-1401	PB1401 - Efficacy of Prophylactic Emicizumab in Type III Von Willebrand Disease Patients: A Two Case Reports	Ohoud Kashari	Received

PB-1403	PB1403 - Evaluation of Interference Compromising Determination of VWF:GPIbM by INNOVANCE VWF Ac Assay	Andrew Podd	Received

PB-1408	PB1408 - Factor-ONE-ing in surgery: survey of perioperative care for hereditary fibrinogenemias in the US	Nicoletta Machin	Received

PB-1412	PB1412 - Genetic characteristics of patients with Factor XI deficiency	Rosa Sonja Alesci	Received

PB-1415	PB1415 - HEAVY MENSTRUAL BLEEDING IN VON WILLEBRAND DISEASE: AN UNRECOGNISED PROBLEM IN CLINICAL EVALUATION	CRISTINA Pascual -Izquierdo	Received

PB-1419	PB1419 - Impact of Cannabis on Joint Health in Hemophilic Patients on Extended Half-Life FVIII Prophylaxis	JUAN GUILLERMO DUQUE ORTEGA	Received

PB-1423	PB1423 - Joint bleed diagnosis and treatment delays in people with hemophilia: Global real-world data	Sinead Stewart	Received

PB-1426	PB1426 - Joint hypermobility is highly prevalent in a bleeding disorder referral population	Callie Berkowitz	Received

PB-1427	PB1427 - Joint problems in female patients with haemophilia in 2024- still neglected	Rosa Sonja Alesci	Received

PB-1430	PB1430 - Large Xq deletion including F8 and F9 with normal factor VIII and factor IX activity levels	Miguel Escobar	Received

PB-1433	PB1433 - Longitudinal observation of pain status in a cohort of patients in a tertiary haemophilia centre	Katharina Holstein	Received

PB-1435	PB1435 - Long-Term Secondary Factor VIII Prophylaxis in a Hemophilia A Mouse Model Lacking Inhibitor Response	Lara Monica	Received

PB-1436	PB1436 - Lymphangiogenesis and iron clearance after hemarthrosis in FVIIIKO mice are FVIII dependent	Bilgimol Chumappumkal Joseph	Received

PB-1439	PB1439 - Monitoring joint health in hemophilia patients in Spain: Updated analysis of the joint US project	Ibone Gonzalez	Received

PB-1457	PB1457 - Prevalence of Synovitis in Patients with Haemophilia A: An interim report of the epidemiologic multicenter observational study	Marius Brühl	Received

PB-1462	PB1462 - Quality of life in Bleeding Disorder of Unknown Cause vs. other mucocutaneous bleeding disorders	Callie Berkowitz	Received

PB-1464	PB1464 - Rare Combined Congenital Bleeding Disorder- Bernard-Soulier and vWD	Joanna Larson	Received

PB-1466	PB1466 - Real-world Recombinant Von Willebrand Factor Prophylaxis in Children with Von Willebrand Disease	Ciji Cabrera	Received

PB-1467	PB1467 - Real-world Recombinant Von Willebrand Factor Prophylaxis in Type 1 or 2 Von Willebrand Disease	Ciji Cabrera	Received

PB-1468	PB1468 - Regular physical activity improves quality of life of people with hemophilia: Ukrainian single center study in a real-life cohort	Tetiana Lymanets	Received

PB-1470	PB1470 - Safety Assessment of a New Fibrinogen Concentrate in Patients with Congenital Fibrinogen Deficiency	Eugenio Rosado	Received

PB-1478	PB1478 - The effect of concizumab on thrombin generation in FVII deficient plasma	Marianne Kjalke	Received

PB-1488	PB1488 - Von Willebrand assay data from UKNEQASBC scheme 2010-2024	christopher reilly-stitt	Received

PB-1489	PB1489 - Von Willebrand Disease Aging and Bleeding Correlation (VWD ABC) Study	Craig Seaman	Received

PB-1490	PB1490 - VWD Connect Foundation Severe Von Willebrand Disease Patient Registry: A Longitudinal Natural History and Patient Outcomes Study	Johnna Cesta	Received

PB-1493	PB1493 - A family series of ACTN1-related thrombocytopaenia with an absent bleeding phenotype	Luke Attwell	Received

PB-1494	PB1494 - A Novel ABCG8 Variant in Sitosterolemia: Impact on Platelet Function and Antithrombotic Therapy	ANA MARIN QUILEZ	Received

PB-1495	PB1495 - A novel in-frame deletion in MYH9 gene in patient with macrothrombocytopenia	Yu Yan Carmen LEE	Received

PB-1498	PB1498 - Absence of platelet dense granules and bleeding diathesis in Hermansky-Pudlak syndrome	Daniel Zaldumbide	Received

PB-1502	PB1502 - Analysis of a case with thrombocytopenia and recurrent myocardial infarction	Xu Ye	Received

PB-1507	PB1507 - Avatrombopag reduces platelet transfusion requirements in chemotherapy-induced thrombocytopenia	ASER ALONSO CARBALLO	Received

PB-1518	PB1518 - Clinical history and management of Glanzmann Thrombasthenia: A retrospective chart review	George Morgan	Received

PB-1521	PB1521 - Co-inheritance of LOF and GOF ITGB3 variants in Glanzmann Thrombasthenia: mechanistic studies	JOSE RIVERA POZO	Received

PB-1525	PB1525 - Diagnostic Accuracy of a Semi-Automatic Microchip Flow Chamber for Platelet Function Disorders	David Schmidt	Received

PB-1529	PB1529 - Dynamic Time-Course Analysis in Coagulation Profile Post rFVIIa Administration In Glanzman Patients	Ahmad Tarawah	Received

PB-1530	PB1530 - Effectiveness of adjunctive caplacizumab treatment in immune thrombotic thrombocytopenic purpura	Gabriele Sapuppo	Received

PB-1534	PB1534 - Establishing a Refence Interval for the Ratio of GPIb/IX and GPIIb/IIIa Expression by Flow Cytometry	Juliana Perez Botero	Received

PB-1539	PB1539 - Genophenotypic Study of Patients with Suspected Inherited Platelet Disorders: Mayo Clinic Experience	Dong Chen	Received

PB-1545	PB1545 - Impact of Iron Deficiency Anaemia & Heavy Menstrual Bleeding in Glanzmann Thrombasthenia	George Morgan	Received

PB-1565	PB1565 - Pathogenicity assessment of a Novel RUNX1 Variant Drives Early FPDMM Diagnosis and Management	ANA MARIN	Received

PB-1569	PB1569 - Platelet Electron Microscopic Dense Granule Analysis: A Multiyear Study Through Proficiency Testing	Dong Chen	Received

PB-1592	PB1592 - UKNEQAS (Blood Coagulation) launches pilot Platelet Glycoprotein exercise May 2024.	christopher reilly-stitt	Received

PB-1594	PB1594 - Unveiling the Unmet Need in Glanzmann Thrombasthenia: Insights from the ATHN Transcends GT Module Natural History Study	Divyaswathi Citla - Sridhar	Received

PB-1596	PB1596 - Whole blood impedance aggregometry to assess the haemostatic potential of platelets post-transfusion	Fergal McGlynn	Received

PB-1598	PB1598 - A new prototype automated assay measuring microvesicles tissue factor-dependent FXa generation	Loris Vallier	Received

PB-1599	PB1599 - An international collaboration to characterize thrombotic events in TEMPI Syndrome	Graham Parker	Received

PB-1606	PB1606 - Coagulation profile of convalescent plasma donors and recipients	Riitta Lassila	Received

PB-1630	PB1630 - IMPAIRED ENDOTHELIAL FUNCTION AND ANGIOGENESIS IN GLANZMANN THROMBASTHENIA	Loredana Bury	Received

PB-1631	PB1631 - IMPAIRED ENDOTHELIAL FUNCTION AND ANGIOGENESIS IN HERMANSKY-PUDLAK SYNDROME (HPS) TYPE 1	Loredana Bury	Received

PB-1671	PB1671 - Thrombin generation and fibrin clot structure in nephrotic patients with primary glomerular disorder	Alessandro Casini	Received

PB-1676	PB1676 - Treatment and outcomes of subclinical valve thrombosis after transcatheter aortic valve replacement	Julia Sharobim	Received

PB-1677	PB1677 - Trends in Mortality Due to Disseminated Intravascular Coagulation in the United States: Geographic and Metropolitan Area Disparities from 1999-2020	Fatima Tuz Zahra	Received

PB-1678	PB1678 - Unlocking Vasculogenic Stem Cell ontogeny: Image Cytometry Differentiates CD34 and CD133 Profiles	david smadja	Received

PB-1683	PB1683 - Acute care utilization in antiphospholipid syndrome and/or systemic lupus erythematosus	Leslie Skeith	Received

PB-1693	PB1693 - Clinical Impact of the Integrated Testing Algorithm for the Detection of a Lupus Anticoagulant	Neel Hegde	Received

PB-1694	PB1694 - Clinical utility of thrombin generation in patients with thrombophilia	Kristina Vrotniakaite-Bajerciene	Received

PB-1698	PB1698 - COMPARISON of three strategies for pulmonary embolism diagnosis : a randomized controlled trial	Romain Le Pennec	Received

PB-1707	PB1707 - HERDOO2 rule to identify unprovoked VTE women who can discontinue: Can I use Non-Vidas D-Dimer?	Harika Dasari	Received

PB-1711	PB1711 - Impact of baseline thrombocytopenia on early outcomes in patients with acute venous thromboembolism	Manuel Monreal	Received

PB-1713	PB1713 - Impact of Pulmonary Hypertension on hospitalization outcomes in patients with Myeloproliferative Neoplasms	Nikhil Vojjala	Received

PB-1716	PB1716 - Inherited thrombophilia and persistent left ventricular thrombus after myocardial infarction	Anna Hojda	Received

PB-1727	PB1727 - Mortality Prediction in Acute Pulmonary Embolism Through AI-Powered Electrocardiogram Analysis	Damon Houghton	Received

PB-1734	PB1734 - Platelet hyperaggregability is not present in patients with inherited thrombophilia and thrombosis.	Petr Kessler	Received

PB-1740	PB1740 - Safety and Efficiency of PE Diagnostic Strategies in Patients with Chronic Lung Disease: an IPDMA.	Vicky Mai	Received

PB-1743	PB1743 - Temporal Dynamics of Extracellular Vesicles in Two Patients with Severe COVID-19	Gabriel Dumitrescu	Received

PB-1744	PB1744 - Temporal patterns of venous thromboembolism incidence and mortality in Finland	Lasse Myllylahti	Received

PB-1747	PB1747 - The patients with venous thromboembolism with and without the history of a previous arterial event are there any differences?	Jana Hirmerová	Received

PB-1753	PB1753 - Thrombosis in antiphospholipid syndrome patients after nearly 1000 patient-years of follow-up	Gustavo Balbi	Received

PB-1756	PB1756 - Time Trends in All-Cause Mortality After First-Time Pulmonary Embolism in Adults Aged 1849 Years	Katarina Glise Sandblad	Received

PB-1761	PB1761 - Utility of PT and Anti-Xa to complement anticoagulation screening in Lupus Anticoagulation testing	Jesse Qiao	Received

ISTH 2025 Congress

June 21-25, Washington

About us

Search and consult posters online
in an exclusive section
for each poster

ACTIVE FROM 21/06/2025 TO 25/06/2025

Poster
Gallery

Upload
Poster

Featured Poster

Vote poster

Poster Discussion
Forum



		Digital Object Identifier. Official code used to identify documents published on internet; similar to ISBN for books. You may use this code to reference your poster in future scientific publications or CVs. It can be found from anywhere in the world. To find the poster page, log onto www.medra.org and enter the DOI, or enter in your internet browser https://dx.doi.org/ followed by the DOI string asigned to your congress.

About us

Terms and Conditions

Special Access

Commercial Web Access